Breaking News

Trials & Filings in Brief: Nov. 21, 2013

By Gil Roth | November 21, 2013

Forest Labs, Gedeon Richter, GSK, Lundbeck, Nanotherapeutics, Otsuka, Pfizer,

Phase I
Pfizer, GSK study combo for melanoma . . . read more

Filings
Forest, Richter Schizophrenia Drug Gets CRL . . . read more

Nanotherapeutics meets with FDA over vax-facility . . . read more

Otsuka, Lundbeck monthly Abilify approved in Europe . . . read more

blog comments powered by Disqus